Literature DB >> 20667923

Pure erythropoiesis in clear cell renal cell carcinoma.

Geoffrey A Talmon1.   

Abstract

Extramedullary hematopoiesis (EMH) is a phenomenon in which benign immature hematopoietic cells are found in sites other than the bone marrow. Although usually associated with an underlying hematologic abnormality such as myelofibrosis, it can be found in some physiologic states or occasionally within solid tumors. In most instances, foci of EMH contain elements of all cell lineages. Presented here is the second reported case of EMH occurring in a low-grade clear cell renal cell carcinoma in a patient without evidence of hematologic disease. As previously, it manifested as pure erythropoiesis as confirmed by morphology and immunohistochemistry. It is possible that this finding is related to erythropoietin secretion by the tumor and not hematologic malignancy.

Entities:  

Mesh:

Year:  2010        PMID: 20667923     DOI: 10.1177/1066896910376769

Source DB:  PubMed          Journal:  Int J Surg Pathol        ISSN: 1066-8969            Impact factor:   1.271


  5 in total

1.  Basic Parameters of Blood Count as Prognostic Factors for Renal Cell Carcinoma.

Authors:  Grzegorz Prokopowicz; Marcin Życzkowski; Krzysztof Nowakowski; Rafał Bogacki; Piotr Bryniarski; Andrzej Paradysz
Journal:  Biomed Res Int       Date:  2016-12-26       Impact factor: 3.411

2.  Extramedullary haematopoiesis in the kidney.

Authors:  Davide Ricci; Marcora Mandreoli; Massimo Valentino; Elena Sabattini; Antonio Santoro
Journal:  Clin Kidney J       Date:  2012-04

3.  Extramedullary hematopoiesis secondary to malignant solid tumors: a case report and literature review.

Authors:  Youting Bao; Zhichao Liu; Meiying Guo; Butuo Li; Xindong Sun; Linlin Wang
Journal:  Cancer Manag Res       Date:  2018-06-08       Impact factor: 3.989

4.  Glutamate transporter SLC1A1 is associated with clear cell renal cell carcinoma

Authors:  Sercan Ergün; Sezgin Güneş; Recep Büyükalpelli; Oğuz Aydın
Journal:  Turk J Med Sci       Date:  2019-04-18       Impact factor: 0.973

Review 5.  Functional significance of erythropoietin in renal cell carcinoma.

Authors:  Christudas Morais; David W Johnson; David A Vesey; Glenda C Gobe
Journal:  BMC Cancer       Date:  2013-01-10       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.